XCSESTENO
Market cap3mUSD
Dec 23, Last price
1.32DKK
1D
1.54%
1Q
-42.11%
IPO
-96.28%
Name
Stenocare A/S
Chart & Performance
Profile
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. It offers medical cannabis oil products. Stenocare A/S was incorporated in 2017 and is based in Randers, Denmark.
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
Income | ||||||
Revenues | 3,758 -16.30% | 4,490 185.05% | 1,575 693.65% | |||
Cost of revenue | 10,178 | 10,899 | 15,653 | |||
Unusual Expense (Income) | ||||||
NOPBT | (6,420) | (6,410) | (14,078) | |||
NOPBT Margin | ||||||
Operating Taxes | (1,253) | (1,584) | (1,527) | |||
Tax Rate | ||||||
NOPAT | (5,167) | (4,825) | (12,551) | |||
Net income | (17,570) 7.77% | (16,303) 28.04% | (12,732) 8.03% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 17,896 | |||||
BB yield | -50.53% | |||||
Debt | ||||||
Debt current | 8,746 | 6,102 | 255 | |||
Long-term debt | 2,311 | 6,479 | 2,231 | |||
Deferred revenue | ||||||
Other long-term liabilities | 1,053 | 315 | ||||
Net debt | 1,559 | 8,151 | (9,235) | |||
Cash flow | ||||||
Cash from operating activities | (10,041) | (15,033) | (13,344) | |||
CAPEX | (176) | (936) | (3,270) | |||
Cash from investing activities | (177) | (937) | (2,539) | |||
Cash from financing activities | 15,287 | 8,679 | 1,243 | |||
FCF | 492 | (6,391) | (15,502) | |||
Balance | ||||||
Cash | 9,498 | 4,429 | 11,720 | |||
Long term investments | ||||||
Excess cash | 9,311 | 4,205 | 11,641 | |||
Stockholders' equity | 25,822 | 24,143 | 40,243 | |||
Invested Capital | 26,194 | 31,889 | 30,159 | |||
ROIC | ||||||
ROCE | ||||||
EV | ||||||
Common stock shares outstanding | 13,944 | 12,099 | 12,088 | |||
Price | 2.54 -72.36% | 9.19 -11.12% | 10.34 -47.35% | |||
Market cap | 35,418 -68.15% | 111,193 -11.04% | 124,986 -42.92% | |||
EV | 36,977 | 119,344 | 115,751 | |||
EBITDA | (3,036) | (3,097) | (12,991) | |||
EV/EBITDA | ||||||
Interest | 2,876 | 1,295 | 213 | |||
Interest/NOPBT |